NTLA - Intellia Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - NTLA (1652130)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
26 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-10-02
NTLADube Michael PVP, Chief Accounting OfficerS - Sale$19.01-2,01247,012-4%-$38,248
2024-07-01
NTLAClark ElianaEVP, Chief Technical OfficerS - Sale$22.93-40571,470-1%-$9,287
2024-06-17
NTLAVerwiel FrankDirS - Sale$25.00-1,50517,948-8%-$37,625
D
2024-03-04
NTLABasta JamesEVP, GCS - Sale+OE$32.99-2,29781,571-3%-$75,778
D
2024-03-04
NTLAClark ElianaEVP, Chief Technical OfficerS - Sale+OE$32.99-60571,470-1%-$19,959
2024-01-08
NTLASepp-Lorenzino LauraEVP, Chief Scientific OfficerS - Sale$28.87-2,27543,927-5%-$65,682
2024-01-03
NTLALeonard John MPres, CEOS - Sale$29.46-19,223904,901-2%-$566,310
2024-01-03
NTLALebwohl DavidEVP, Chief Medical OfficerS - Sale$29.46-5,84354,372-10%-$172,135
2024-01-03
NTLASepp-Lorenzino LauraEVP, Chief Scientific OfficerS - Sale$29.46-5,53246,202-11%-$162,973
2024-01-03
NTLAGoddard GlennEVP, CFOS - Sale$29.46-5,36540,585-12%-$158,053
2024-01-03
NTLAHicks DerekEVP, Chief Business OfficerS - Sale$29.46-3,87736,987-9%-$114,216
2024-01-03
NTLABasta JamesEVP, GCS - Sale$29.46-3,80551,474-7%-$112,095
2024-01-03
NTLAClark ElianaEVP, Chief Technical OfficerS - Sale$29.50-4,60840,845-10%-$135,954
2023-10-31
NTLABhanji MunaDirS - Sale$23.90-26511,996-2%-$6,334
2023-07-31
NTLABhanji MunaDirS - Sale$42.33-26512,261-2%-$11,217
2023-07-06
NTLABhanji MunaDirS - Sale$39.30-1,86712,526-13%-$73,373
2023-07-03
NTLAClark ElianaEVP, Chief Technical OfficerS - Sale$40.51-36045,146-1%-$14,584
D
2023-06-20
NTLAClark ElianaEVP, Chief Technical OfficerS - Sale+OE$45.00-5,00045,146-10%-$225,000
D
2023-03-02
NTLABasta JamesEVP, GCS - Sale+OE$43.88-1,08855,279-2%-$47,741
M
2023-01-04
NTLASepp-Lorenzino LauraEVP, Chief Scientific OfficerS - Sale$37.82-4,83817,629-22%-$182,982
2023-01-04
NTLALeonard John MPres, CEOS - Sale$37.21-6,673825,240-1%-$248,302
2023-01-04
NTLAHicks DerekEVP, Chief Business OfficerS - Sale$37.21-1,81217,306-9%-$67,425
2023-01-04
NTLALebwohl DavidEVP, Chief Medical OfficerS - Sale$37.21-2,57425,687-9%-$95,779
2023-01-04
NTLAGoddard GlennEVP, CFOS - Sale$37.21-2,42715,404-14%-$90,309
M
2022-07-01
NTLAClark ElianaEVP, Chief Technical OfficerS - Sale$37.65-2,02814,473-12%-$76,357
2023-01-04
NTLABasta JamesEVP, GCS - Sale$37.21-1,13819,559-5%-$42,345

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top